Clarifying assent in pediatric research
- PMID: 23756442
- PMCID: PMC3895639
- DOI: 10.1038/ejhg.2013.119
Clarifying assent in pediatric research
Abstract
Assent is a relatively young term in research ethics, but became an often mentioned ethical requirement in current pediatric research guidelines. Also, the European Society of Human Genetics considers assent an important condition for the inclusion of children in biobanks. However, although many emphasize the importance of assent, few explain how they understand the concept and few have elaborated on the underlying grounds. In this paper, we will discuss the different underlying ethical principles of assent. In the first category, assent appears to be derived from informed consent. This understanding is grounded in respect for autonomy and protection against harm. We conclude that this interpretation of assent is not of added value as a majority of children cannot be considered competent to make autonomous decisions. In addition, other safeguards are more appropriate to protect children against harm. The grounds from the second category can be classified as engagement grounds. These grounds do justice to the specifics of childhood and are of added value. Furthermore, we argue that it follows that both the content and the process of assent should be adjusted to the individual child. This can be referred to as personalized assent. Personalized assent is an appeal to the moral responsibility and integrity of the researcher.
Comment in
-
Is a requirement of personalised assent realistic? A case from the GABRIEL project.Eur J Hum Genet. 2014 Jul;22(7):855. doi: 10.1038/ejhg.2013.259. Epub 2013 Nov 6. Eur J Hum Genet. 2014. PMID: 24193345 Free PMC article. No abstract available.
-
Reply to Waligora.Eur J Hum Genet. 2014 Jul;22(7):855. doi: 10.1038/ejhg.2013.260. Epub 2013 Nov 6. Eur J Hum Genet. 2014. PMID: 24193347 Free PMC article. No abstract available.
References
-
- Salvaterra E, Giorda R, Bassi MT, et al. Pediatric biobanking: a pilot qualitative survey of practices, rules, and researcher opinions in ten European countries. Biopreserv Biobank. 2012;10:29–36. - PubMed
-
- Gilheeney SW, Kieran MW. Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters. Future Oncol. 2012;8:549–558. - PubMed
-
- Pedersen M, Merlo DF, Knudsen LE. Ethical issues related to biomonitoring studies on children. Int J Hyg Environ Health. 2007;210:479–482. - PubMed
-
- Van Larebeke NA, Birnbaum LS, Boogaerts MA, et al. Unrecognized or potential risk factors for childhood cancer. Int J Occup Environ Health. 2005;11:199–201. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
